PATEO (02889) is now in the Overvalued zone, suggesting that its current forward PS ratio of 6.62 is considered Overvalued compared with the five-year average of -112.85. The fair price of PATEO (02889) is between 11.11 to 151.87 according to relative valuation method. Compared to the current price of 210.00 USD , PATEO By Overvalued By 38.27%.

Relative Value

Fair Zone

11.11-151.87

Current Price：210.00

38.27%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is PATEO (02889) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

PATEO (02889) has a current Price-to-Book (P/B) ratio of 19.68. Compared to its 3-year average P/B ratio of 16.96, the current P/B ratio is approximately 16.03% higher. Relative to its 5-year average P/B ratio of 16.96, the current P/B ratio is about 16.03% higher. PATEO (02889) has a Forward Free Cash Flow (FCF) yield of approximately -1.00%. Compared to its 3-year average FCF yield of -1.57%, the current FCF yield is approximately -36.31% lower. Relative to its 5-year average FCF yield of -1.57%, the current FCF yield is about -36.31% lower.

Performance Decomposition

AI Analysis

Market capitalization of 02889 increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of 02889 in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is 02889 currently overvalued or undervalued?

What is PATEO (02889) fair value?

02889's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of PATEO (02889) is between 11.11 to 151.87 according to relative valuation method.

How does 02889's valuation metrics compare to the industry average?

The average P/S ratio for 02889's competitors is 0.00, providing a benchmark for relative valuation. PATEO Corp (02889) exhibits a P/S ratio of --, which is 0% above the industry average. Given its robust revenue growth of 0%, this premium appears unsustainable.

What is the current P/B ratio for PATEO (02889) as of Mar 04 2026?

As of Mar 04 2026, PATEO (02889) has a P/B ratio of 19.68. This indicates that the market values 02889 at 19.68 times its book value.

What is the current FCF Yield for PATEO (02889) as of Mar 04 2026?

As of Mar 04 2026, PATEO (02889) has a FCF Yield of -1.00%. This means that for every dollar of PATEO's market capitalization, the company generates -1.00 cents in free cash flow.

What is the current Forward P/E ratio for PATEO (02889) as of Mar 04 2026?

As of Mar 04 2026, PATEO (02889) has a Forward P/E ratio of -276.55. This means the market is willing to pay $-276.55 for every dollar of PATEO's expected earnings over the next 12 months.

What is the current Forward P/S ratio for PATEO (02889) as of Mar 04 2026?

As of Mar 04 2026, PATEO (02889) has a Forward P/S ratio of 6.62. This means the market is valuing 02889 at $6.62 for every dollar of expected revenue over the next 12 months.

02889 Valuation